www.fdanews.com/articles/80746-proteome-systems-raises-10m-through-a-private-placement-to-institutional-and-professional-investors
PROTEOME SYSTEMS RAISES $10M THROUGH A PRIVATE PLACEMENT TO INSTITUTIONAL AND PROFESSIONAL INVESTORS
September 8, 2005
Proteome Systems announced it has completed a conditional private placement
to institutional and professional investors raising approx $10 million at $0.30
per share. The proceeds will allow the Company to accelerate development of
its TB test and undertake clinical development of its scavenger drugs for dermatological
conditions. Proteome Systems (ASX: PXL) today announced that it will raise approximately
$10 million through the issue of up to 33,333,333 fully paid ordinary shares
to institutional and professional investors in the UK, US and Australia at a
price of $0.30c per share.
EurekAlert!